T. Rowe Price Associates’s Innovid Corp. CTV Stock Holding History

T. Rowe Price Associates’s Portfolio CTV Stock Details CTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-44,179	Closed	-$137K	–	3096
2024 Q4	$137K	Buy	44,179 +9,968	+29%	+$23.5K	﹤0.01%	2786
2024 Q3	$62K	Hold	34,211	–	–	﹤0.01%	2905
2024 Q2	$0	Buy	+34,211	New	+$73.3K	﹤0.01%	3052
2023 Q3	–	Sell	-32,640	Closed	-$36K	–	2918
2023 Q2	$36K	Buy	32,640 +19,341	+145%	+$20.1K	﹤0.01%	2838
2023 Q1	$19K	Hold	13,299	–	–	﹤0.01%	2864
2022 Q4	$23K	Buy	13,299 +1,480	+13%	+$4.01K	﹤0.01%	2870
2022 Q3	$33K	Buy	+11,819	New	+$33.7K	﹤0.01%	2880

T. Rowe Price Associates's CTV Position: Q1 2025 in Review

T. Rowe Price Associates sold out of Innovid Corp. (CTV) in Q1 2025, closing a stake of 44,179 shares — an estimated $137K sold.

T. Rowe Price Associates first reported a position in CTV in Q3 2022 and held it in 7 quarters. The position peaked at $137K in Q4 2024. 0 funds tracked by Wall St. Rank hold CTV as of Q1 2025.

T. Rowe Price Associates reported no remaining Innovid Corp. position as of Q1 2025 after selling out during the quarter.
T. Rowe Price Associates sold 44,179 Innovid Corp. shares in Q1 2025, an estimated $137K.
T. Rowe Price Associates first reported a position in Innovid Corp. in Q3 2022 and held it in 7 quarters.
T. Rowe Price Associates's Innovid Corp. position peaked at $137K in Q4 2024.
0 funds tracked by Wall St. Rank held Innovid Corp. as of Q1 2025.

Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.